Alvogen Lux Holdings

Alvogen is a global pharmaceutical company specialized in the development, manufacture, and marketing of generic, brand, over-the-counter (OTC), and biosimilar products. The company operates a diverse portfolio across high-growth therapeutic areas including oncology, cardiology, respiratory, and neurology, with a commercial presence in over 35 countries. Alvogen leverages a complex global supply chain and strategic subsidiaries, such as Lotus Pharmaceutical in Asia and Adalvo for B2B licensing, to maintain its competitive position. The company is notably active in the biosimilar space through its long-standing partnership with Alvotech, focusing on expanding access to affordable biologic therapies.